You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

vedolizumab

Showing 1 - 25 of 57
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Crohn's Disease Trial in Chicago (Vedolizumab, Adalimumab, Ustekinumab)

Not yet recruiting
  • Crohn's Disease
  • Vedolizumab
  • +2 more
  • Chicago, Illinois
    University of Chicago Medicine
Sep 13, 2023

Crohn Disease Trial (Upadacitinib, Vedolizumab)

Not yet recruiting
  • Crohn Disease
  • (no location specified)
Oct 18, 2023

Ulcerative Colitis Trial in Los Angeles (Vedolizumab, Tofacitinib)

Not yet recruiting
  • Ulcerative Colitis
  • Los Angeles, California
    Cedars Sinai Medical Center
Oct 18, 2023

Safety and Efficacy Trial in Suzhou (Basiliximab, Vedolizumab)

Recruiting
  • Safety and Efficacy
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Sep 27, 2023

Immune-Mediated Colitis Trial in Herlev (Vedolizumab, Prednisolone)

Recruiting
  • Immune-Mediated Colitis
  • Herlev, Denmark
    Herlev University Hospital
Aug 16, 2022

Type 1 Diabetes Trial in La Jolla, Seattle (Etanercept, Vedolizumab)

Recruiting
  • Type 1 Diabetes
  • La Jolla, California
  • +1 more
Jul 21, 2022

Ulcerative Colitis Trial in Zhengzhou (Vedolizumab)

Recruiting
  • Ulcerative Colitis
  • Vedolizumab
  • Zhengzhou, Hangzhou, China
    Second Affiliated Hospital Zhejiang University School of Medicin
Jul 28, 2022

Colitis, Ulcerative Trial in Worldwide (Vedolizumab)

Recruiting
  • Colitis, Ulcerative
  • Vedolizumab
  • Minneapolis, Minnesota
    MNGI Digestive Health, PA
Jan 21, 2022

Vedolizumab for IV Infusion 300 mg [Ulcerative Colitis]

Recruiting
  • Ulcerative Colitis
  • Vedolizumab
  • Tokyo, Japan
    Takeda Selected Site
Apr 26, 2022

Ulcerative Colitis, Crohn's Disease Trial in Japan (Vedolizumab)

Recruiting
  • Ulcerative Colitis
  • Crohn's Disease
  • Vedolizumab
  • Toyota, Aichi, Japan
  • +19 more
Jun 9, 2022

IBD Trial in Kiel (Infliximab, Vedolizumab)

Completed
  • IBD
  • Kiel, Germany
    Medical Department I, University Hospital Schleswig-Holstein
Jun 30, 2022

Crohn's Disease, Ulcerative Colitis, Inflammatory Bowel Disease Trial in Worldwide (Vedolizumab)

Completed
  • Crohn's Disease
  • +2 more
  • Vedolizumab
  • Morristown, New Jersey
  • +14 more
May 4, 2022

Crohn Disease Trial in France (Vedolizumab)

Recruiting
  • Crohn Disease
  • Vedolizumab
  • Paris, Le Kremlin-Bicêtre, France
  • +4 more
Sep 20, 2021

Combined Microbiota and Metabolic Signature in Ulcerative

Not yet recruiting
  • Ulcerative Colitis
  • (no location specified)
Jan 26, 2023

Crohn's Disease and Ulcerative Colitis Trial in Seoul (Vedolizumab)

Not yet recruiting
  • Crohn's Disease and Ulcerative Colitis
  • Vedolizumab
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Jun 7, 2021

A Multicentered Prospective Cohort Study of Chinese IBD Patients

Enrolling by invitation
  • Ulcerative Colitis
  • Crohn Disease
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
May 17, 2022

Locally Advanced or Recurrent/Metastatic Salivary Gland Carcinoma, Neoadjuvant or Conversion Therapy, Precision Therapy Trial in

Recruiting
  • Locally Advanced or Recurrent/Metastatic Salivary Gland Carcinoma
  • +2 more
  • Vedolizumab
  • +5 more
  • Beijing, Beijing, China
  • +1 more
Nov 21, 2023

Pouchitis Trial in Worldwide (Vedolizumab Placebo, Ciprofloxacin, Vedolizumab)

Completed
Has Results
  • Pouchitis
  • Vedolizumab Placebo
  • +2 more
  • Chicago, Illinois
  • +33 more
Feb 1, 2022

ULCERATIVE COLITIS Trial in France (VEDOLIZUMAB, ADALIMUMAB)

Terminated
  • ULCERATIVE COLITIS
  • Angers, France
  • +3 more
Feb 2, 2021

Colitis, Ulcerative, Crohn's Disease Trial in United States (Vedolizumab)

Completed
Has Results
  • Colitis, Ulcerative
  • Crohn's Disease
  • Vedolizumab
  • Aurora, Colorado
  • +6 more
Dec 16, 2020

Ulcerative Colitis - Vedolizumab- With/Without Prior Exposure to

Terminated
  • Ulcerative Colitis
  • Vedolizumab
  • Stanford, California
  • +1 more
Dec 17, 2020

Crohn Disease Trial in Canada, United States (Vedolizumab, Adalimumab, Methotrexate)

Completed
Has Results
  • Crohn Disease
  • Vedolizumab
  • +2 more
  • Dothan, Alabama
  • +31 more
Jul 11, 2022

Colitis, Ulcerative, Crohn Disease Trial in Cypress, Miami (Caffeine, Losartan, Omeprazole)

Withdrawn
  • Colitis, Ulcerative
  • Crohn Disease
  • Cypress, California
  • +1 more
Oct 23, 2020

Ulcerative Colitis Trial in Milwaukee (Tacrolimus, Vedolizumab, Placebo)

Terminated
Has Results
  • Ulcerative Colitis
  • Milwaukee, Wisconsin
    Medical College of Wisconsin
Aug 17, 2020

Ulcerative Colitis, Efficacy, Self, Biologics Trial in China (Infliximab, Vedolizumab, Mesalazine)

Not yet recruiting
  • Ulcerative Colitis
  • +3 more
  • Chongqing, Chongqing, China
  • +10 more
Jan 11, 2022